Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33316634

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2021 Feb
First author
Berlanga P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Berlanga P
      type
      Author
    2. name
      Pasqualini C
      type
      Author
    3. name
      Pötschger U
      type
      Author
    4. name
      Sangüesa C
      type
      Author
    5. name
      Castellani MR
      type
      Author
    6. name
      Cañete A
      type
      Author
    7. name
      Luksch R
      type
      Author
    8. name
      Elliot M
      type
      Author
    9. name
      Schreier G
      type
      Author
    10. name
      Kropf M
      type
      Author
    11. name
      Morgenstern D
      type
      Author
    12. name
      Papadakis V
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Berlanga P
      type
      Author
    2. name
      Pasqualini C
      type
      Author
    3. name
      Pötschger U
      type
      Author
    4. name
      Sangüesa C
      type
      Author
    5. name
      Castellani MR
      type
      Author
    6. name
      Cañete A
      type
      Author
    7. name
      Luksch R
      type
      Author
    8. name
      Elliot M
      type
      Author
    9. name
      Schreier G
      type
      Author
    10. name
      Kropf M
      type
      Author
    11. name
      Morgenstern D
      type
      Author
    12. name
      Papadakis V
      type
      Author
    bibliography ids
    1. nci-bib-bd3c39d996ddff24bb577abb
    book metadata
    content sha256
    79392f03b635400609bdef74907f12a5f6e268aca7e33368d34bb9a8c11f1661
    document type
    citation
    dois
    1. 10.1016/j.ejca.2020.10.020
    electronic publication date
    display
    2020 Dec 11
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33316634
    immutable id
    pubmed:33316634@79392f03b635400609bdef74907f12a5f6e268aca7e33368d34bb9a8c11f1661
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    1-8
    volume
    144
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33316634
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      25be8f55093a83be9a1d149d2d1113a60da22a42d07a90190cf0995bfc9cf5f9
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Feb
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33316634/
      title
      Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.

      Preserved source evidence · Not medical advice